INTERGRATED DIA.H DL 025 (8I8) - Cash Flow Conversion Efficiency
Based on the latest financial reports, INTERGRATED DIA.H DL 025 (8I8) has a cash flow conversion efficiency ratio of 0.096x as of June 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€340.79 Million ≈ $398.42 Million USD) by net assets (€3.55 Billion ≈ $4.15 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 8I8 market cap overview for the company's overall valuation and market capitalisation.
INTERGRATED DIA.H DL 025 - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how INTERGRATED DIA.H DL 025's cash flow conversion efficiency has evolved over time, based on yearly financial data.
INTERGRATED DIA.H DL 025 Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of INTERGRATED DIA.H DL 025 ranked by their cash flow conversion efficiency. Explore INTERGRATED DIA.H DL 025 earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
China Western Power Industrial Co Ltd
SHE:002630
|
0.072x |
|
Guiyang Xintian Pharmaceutical Co Ltd
SHE:002873
|
0.039x |
|
Valuetronics Holdings Limited
F:GJ7
|
0.021x |
|
Omni Bridgeway Ltd
AU:OBL
|
-0.051x |
|
CompX International Inc
NYSE MKT:CIX
|
0.087x |
|
Yantai Yatong Precision Mechanical Corp. A
SHG:603190
|
N/A |
|
Resolute Holdings Management, Inc.
NASDAQ:RHLD
|
1.433x |
|
Woori Technology Investment Co. Ltd
KQ:041190
|
0.000x |
Annual Cash Flow Conversion Efficiency for INTERGRATED DIA.H DL 025 (2021–2025)
The table below shows the annual cash flow conversion efficiency of INTERGRATED DIA.H DL 025 from 2021 to 2025. View INTERGRATED DIA.H DL 025 stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €4.13 Billion ≈ $4.83 Billion |
€1.90 Billion ≈ $2.23 Billion |
0.461x | +2.86% |
| 2024-12-31 | €3.50 Billion ≈ $4.09 Billion |
€1.57 Billion ≈ $1.83 Billion |
0.448x | +155.65% |
| 2023-12-31 | €3.10 Billion ≈ $3.63 Billion |
€543.66 Million ≈ $635.60 Million |
0.175x | +105.54% |
| 2022-12-31 | €2.45 Billion ≈ $2.86 Billion |
€208.73 Million ≈ $244.03 Million |
0.085x | -89.50% |
| 2021-12-31 | €2.79 Billion ≈ $3.27 Billion |
€2.27 Billion ≈ $2.65 Billion |
0.812x | -- |
About INTERGRATED DIA.H DL 025
Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron… Read more